. Author manuscript; available in PMC: 2022 Apr 1.

Published in final edited form as: Clin Gastroenterol Hepatol. 2021 Apr 8;20(4):e876–e889. doi: 10.1016/j.cgh.2021.04.008

Table 1.

Esophageal biopsy results on initial (index) upper endoscopy and follow-up upper endoscopy for 530 patients. Eleven patients with dysplasia on index EGD, 52 patients with follow-up EGD within 3 months of index EGD, and 32 patients with follow-up EGD > 60 months after index EGD were excluded.

	Index EGD
	Nondysplastic BE (n=271)	BE Indefinite for Dysplasia (n=87)
Follow-Up EGD ≤ 18 months (n=439)
No BE	75 (27.7%)	18 (20.7%)
Nondysplastic BE	147 (54.2%)	41 (47.1%)
BE Indefinite for Dysplasia	38 (14.0%)	16 (18.4%)
Dysplastic BE	11 (4.1%)	12 (13.8%)
	Nondysplastic BE (n=131)	BE Indefinite for Dysplasia (n=9)
Follow-Up EGD 19-60 mo (n=140)
No BE	22 (16.8%)	3 (33.3%)
Nondysplastic BE	79 (60.3%)	5 (55.6%)
BE Indefinite for Dysplasia	18 (13.7%)	1 (11.1%)
Dysplastic BE	12 (9.2%)	0 (0.0%)